Perspectives
Stay up-to-date with the current investment and macroeconomic issues at ClearBridge Investments. We provide analyses of the themes and trends which lie at the heart of your investment challenges.
Global Value Improvers Strategy August Commentary
The Strategy outperformed its benchmark, led by stock selection in Japan, the U.K. and the industrials sector, which more than offset detractors in Europe and the materials sector.
More...
Global Growth Strategy July Commentary
We remain resilient, benefiting from diversified stock selection and attractive valuations despite recent market rotations and challenges in growth sectors.
More...
Expanding to Undervalued Geographies
Q2 2024 Global Growth Strategy Commentary: We are broadening out our geographic footprint with new names to take advantage of ideas where we still see significant upside in technology.
More...
Improvers Outperform on AI Demand
Q2 2024 Global Value Improvers Strategy Commentary: The Strategy outperformed its benchmark, as strong stock selection in our industrials and health care holdings overcame detractors in the financials sector.
More...
Midyear Equity Outlook: Rotation Seems Inevitable
While second-half profit expectations are likely to be reduced, we believe weakness will be contained, and the U.S. economy will avoid a recession.
More...
Transports Poised for Delayed Recovery
An extended contraction in U.S. manufacturing activity has left the transports industry mired in a freight recession, yet the emergence of reshoring and improving operating efficiencies leave high-quality operators attractively positioned for an economic recovery.
More...
Introducing Global Growth
In this video, Portfolio Manager, Michael Testorf is joined by Head of APAC Business Development, Matt Bushby to introduce the Global Growth Strategy. Come along as they explore the Strategy and it's objectives.
More...
Introducing Global Value Improvers
Join Portfolio Manager, Grace Su as she delves into the investment philosophy supporting the ClearBridge Global Value Improvers Strategy, and explores what the Strategy aims to achieve.
More...
International Companies Drive Diabesity Innovation
Diabetes and obesity (“diabesity”) have rapidly become the largest opportunity in health care, with an estimated total long-term addressable market of $100 billion in the U.S. alone. Research & development outside the U.S. has provided actionable insights into the blockbuster market for diabesity treatments.
More...
U.S. Equity Outlook: Market Breadth to Dictate Bullishness
CIO, Scott Glasser explains the importance of greater market participation to extend the current bull market and why high-quality defensive stocks, particularly in health care, are positioned to hold up better than the current mega cap leaders in an economic downturn.
More...
U.S. Economic Outlook: Beware Lagged Effects
The economy is at the crux of this cycle, the most difficult period of headwinds. We expect the lagged effects of Fed tightening to slow economic growth during the first half of 2024 and we continue to maintain our base case of a recession as we move through this period.
More...
Global Value Improvers: A Value Approach to Delivering ESG Gains
ESG investing approaches typically focus on best-in-class companies in growth sectors, overlooking value sectors that carried poor sustainability profiles in the past but are today undertaking powerful new initiatives for improvement.
More...